Center for Scientific Review; Notice of Closed Meetings, 49252-49253 [2015-20213]
Download as PDF
49252
Federal Register / Vol. 80, No. 158 / Monday, August 17, 2015 / Notices
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: September 10, 2015.
Time: 12:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health Room
3F100, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Louis A. Rosenthal, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Rm 3G42B, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC–79823,
Bethesda, MD 20892–9823, (240) 669–5070,
rosenthalla@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 12, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–20211 Filed 8–14–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institutes of Health
Notice of Kidney Interagency
Coordinating Committee Meeting
The Kidney Interagency
Coordinating Committee (KICC) will
hold a meeting on September 25, 2015,
on the pharmacist’s role in chronic
kidney disease care. The meeting is
open to the public.
SUMMARY:
VerDate Sep<11>2014
16:57 Aug 14, 2015
Jkt 235001
The meeting will be held on
September 25, 2015, 9 a.m. to 12 p.m.
Individuals wanting to present oral
comments must notify the contact
person at least 10 days before the
meeting date.
ADDRESSES: The meeting will be held in
the Natcher Conference Center on the
NIH Campus at 9000 Rockville Pike,
Bethesda, MD 20894.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, contact Dr. Andrew S. Narva,
Executive Secretary of the Kidney
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A27, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–594–8864; FAX:
301–480–0243; email: nkdep@
info.niddk.nih.gov.
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The KICC,
chaired by the National Institute of
Diabetes and Digestive and Kidney
Diseases (NIDDK), comprises members
of the Department of Health and Human
Services and other federal agencies that
support kidney-related activities,
facilitates cooperation, communication,
and collaboration on kidney disease
among government entities. KICC
meetings, held twice a year, provide an
opportunity for Committee members to
learn about and discuss current and
future kidney programs in KICC member
organizations and to identify
opportunities for collaboration. The
September 25, 2015 KICC meeting will
focus on the pharmacist’s role in
chronic kidney disease care.
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future KICC meetings should send a
request to nkdep@info.niddk.nih.gov.
Dated: August 4, 2015.
Camille M. Hoover,
Executive Officer, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institutes of Health.
[FR Doc. 2015–20219 Filed 8–14–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Predoctoral
Training Programs in Big Data Science.
Date: September 24, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Feng Tao, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive Room 6184, MSC 7849, Bethesda, MD
20892, (301) 451–3940, feng.tao@nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group, Neurotransporters, Receptors,
and Calcium Signaling Study Section.
Date: September 28–29, 2015.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 700 F Street NW.,
Washington, DC 20001.
Contact Person: Peter B Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4182,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
E:\FR\FM\17AUN1.SGM
17AUN1
49253
Federal Register / Vol. 80, No. 158 / Monday, August 17, 2015 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Shared
Instrumentation: Genomics.
Date: September 30, 2015.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Richard Panniers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212,
MSC 7890, Bethesda, MD 20892, (301) 435–
1741, pannierr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 12, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–20213 Filed 8–14–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute on Minority Health
and Health Disparities; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Minority
Health and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Advisory Council on Minority Health
and Health Disparities.
VerDate Sep<11>2014
16:57 Aug 14, 2015
Jkt 235001
Date: September 10, 2015.
Open: 8:30 a.m. to 2:30 p.m.
Agenda: The agenda will include
opening remarks, administrative
matters, Director’s Report, NIH Health
Disparities update, and other business
of the Council.
Place: National Institutes of Health,
National Institute on Minority Health
and Health Disparities, 31 Center Drive,
Building 31, Conference Room 6,
Bethesda, MD 20892.
Closed: 2:30 p.m. to Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Minority Health
and Health Disparities, 31 Center Drive,
Building 31, Conference Room 6,
Bethesda, MD 20892.
Contact Person: Dr. Joyce Hunter,
Executive Secretary, National Institutes
of Health, National Institute on Minority
Health and Heath Disparities, 6707
Democracy Blvd., Suite 800, Bethesda,
MD 20892, (301) 402–1366, hunterj@
nih.gov.
Any member of the public interested
in presenting oral comments to the
committee may notify the Contact
Person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives of organizations may
submit a letter of intent, a brief
description of the organization
represented, and a short description of
the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee,
presentations may be limited to five
minutes. Both printed and electronic
copies are requested for the record. In
addition, any interested person may file
written comments with the committee
by forwarding their statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxis, hotel,
and airport shuttles, will be inspected
before being allowed on campus.
Visitors will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit).
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Dated: August 12, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–20220 Filed 8–14–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Approval of Freeboard International as
a Commercial Gauger
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of approval of Freeboard
International as a commercial gauger.
AGENCY:
Notice is hereby given,
pursuant to CBP regulations, that
Freeboard International has been
approved to gauge petroleum and
certain petroleum products for customs
purposes for the next three years as of
April 1, 2015.
DATES: Effective Dates: The approval of
Freeboard International as commercial
gauger became effective on April 1,
2015. The next triennial inspection date
will be scheduled for April 2018.
FOR FURTHER INFORMATION CONTACT:
Approved Gauger and Accredited
Laboratories Manager, Laboratories and
Scientific Services Directorate, U.S.
Customs and Border Protection, 1300
Pennsylvania Avenue NW., Suite
1500N, Washington, DC 20229, tel. 202–
344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.13,
that Freeboard International, 2500
Brunswick Ave., Linden, NJ 07036, has
been approved to gauge petroleum and
certain petroleum products for customs
purposes, in accordance with the
provisions of 19 CFR 151.13. Freeboard
International is approved for the
following gauging procedures for
petroleum and certain petroleum
products from the American Petroleum
Institute (API):
SUMMARY:
API
Chapters
1 .....................
3 .....................
7 .....................
8 .....................
12 ...................
17 ...................
Title
Vocabulary.
Tank gauging.
Temperature determination.
Sampling.
Calculations.
Maritime measurement.
Anyone wishing to employ this entity
to conduct gauger services should
request and receive written assurances
from the entity that it is approved by the
E:\FR\FM\17AUN1.SGM
17AUN1
Agencies
[Federal Register Volume 80, Number 158 (Monday, August 17, 2015)]
[Notices]
[Pages 49252-49253]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20213]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Predoctoral Training Programs in Big Data Science.
Date: September 24, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Feng Tao, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive Room 6184, MSC 7849, Bethesda, MD 20892, (301) 451-
3940, feng.tao@nih.gov.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group, Neurotransporters, Receptors,
and Calcium Signaling Study Section.
Date: September 28-29, 2015.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Monaco, 700 F Street NW., Washington, DC 20001.
Contact Person: Peter B Guthrie, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4182, MSC 7850, Bethesda, MD
20892, (301) 435-1239, guthriep@csr.nih.gov.
[[Page 49253]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Shared Instrumentation: Genomics.
Date: September 30, 2015.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Richard Panniers, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212, MSC 7890, Bethesda, MD
20892, (301) 435-1741, pannierr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: August 12, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-20213 Filed 8-14-15; 8:45 am]
BILLING CODE 4140-01-P